Public discussion of gender-affirming medical treatment is typically framed as a moral imperative, as though affirmation itself settles the empirical question. Yet medicine is not an exercise in sentiment. It is an applied science governed by evidence, proportionality, and the obligation to avoid foreseeable harm. When interventions involve endocrine manipulation, permanent sterility, surgical removal of healthy organs, and the interruption of adolescent brain development, the threshold for justification must be exceptionally high. It is precisely here that the current evidence base appears most fragile.
Systematic reviews of puberty blockers and cross-sex hormones for adolescents have repeatedly characterized the supporting evidence as low or very low in quality. The recurring problems are methodological and structural: small sample sizes, short follow-up windows, absence of randomized controls, and heavy reliance on self-reported psychological outcomes rather than objective long-term measures. Improvements in dysphoria or mood are frequently documented within months of intervention, yet the data rarely extend into full adulthood, when the cumulative consequences of hormonal alteration, infertility, and surgical intervention can be meaningfully assessed. To promote irreversible medical pathways for minors while acknowledging that long-term outcome data remain limited is, at minimum, ethically precarious.
Read Full Article: https://amgreatness.com/2026/05/07/the-experiment-on-adolescence/
